This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB08091/identifier/drugbank/
dctermshttp://purl.org/dc/terms/
n13http://linked.opendata.cz/resource/drugbank/drug/DB08091/identifier/chemspider/
n12http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB08091/identifier/pdb/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08091/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n6http://linked.opendata.cz/resource/drugbank/drug/DB08091/identifier/pubchem-substance/

Statements

Subject Item
n2:DB08091
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB08091 n12:DB08091
dcterms:title
3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE
adms:identifier
n6:99444562 n7:LI2 n9:5326868 n13:4484161 n14:DB08091
n3:IUPAC-Name
n4:271B5D42-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B5D48-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B5D47-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5D44-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5D45-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B5D46-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5D40-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5D41-363D-11E5-9242-09173F13E4C5 n4:271B5D3E-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5D3F-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5D4E-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5D4F-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B5D49-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B5D4A-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5D4C-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B5D4B-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5D4D-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5D54-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B5D56-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B5D57-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5D53-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5D52-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5D55-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5D43-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5D50-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5D51-363D-11E5-9242-09173F13E4C5